Study of ECC4703 With Sulfasalazine and Pitavastatin

Clinical trial NCT07726368 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07726368
Sponsor: Eccogene
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-alcoholic Fatty Liver Disease (NAFLD)Dyslipidaemia

Start date: 2026-07-01
Primary completion: 2026-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.